$91.61
+0.97
(+1.07%)▲
0.89%
Downside
Day's Volatility :1.21%
Upside
0.33%
37.55%
Downside
52 Weeks Volatility :37.55%
Upside
0.0%
Period | Encompass Health Corporation | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 9.91% | 6.5% | 0.0% |
6 Months | 26.45% | 7.1% | 0.0% |
1 Year | 37.21% | 9.8% | 0.0% |
3 Years | 12.74% | 14.2% | -20.2% |
Market Capitalization | 9.1B |
Book Value | $17.3 |
Dividend Share | 0.6 |
Dividend Yield | 0.67% |
Earnings Per Share (EPS) | 3.82 |
PE Ratio | 23.73 |
Wall Street Target Price | 99.18 |
Profit Margin | 7.6% |
Operating Margin TTM | 15.77% |
Return On Assets TTM | 7.94% |
Return On Equity TTM | 22.94% |
Revenue TTM | 5.0B |
Revenue Per Share TTM | 49.77 |
Quarterly Revenue Growth YOY | 13.4% |
Gross Profit TTM | 1.8B |
EBITDA | 1.0B |
Diluted Eps TTM | 3.82 |
Quarterly Earnings Growth YOY | 0.27 |
EPS Estimate Current Year | 4.11 |
EPS Estimate Next Year | 4.59 |
EPS Estimate Current Quarter | 0.94 |
EPS Estimate Next Quarter | 1.02 |
What analysts predicted
Upside of 8.26%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 4.3B | ↑ 9.14% |
Net Income | 292.3M | ↑ 14.05% |
Net Profit Margin | 6.83% | ↑ 0.29% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 4.6B | ↑ 7.66% |
Net Income | 358.7M | ↑ 22.72% |
Net Profit Margin | 7.79% | ↑ 0.96% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 4.6B | ↑ 0.86% |
Net Income | 284.2M | ↓ 20.77% |
Net Profit Margin | 6.12% | ↓ 1.67% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 5.1B | ↑ 10.27% |
Net Income | 412.2M | ↑ 45.04% |
Net Profit Margin | 8.05% | ↑ 1.93% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 4.3B | ↓ 15.09% |
Net Income | 271.0M | ↓ 34.26% |
Net Profit Margin | 6.23% | ↓ 1.82% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 4.8B | ↑ 10.41% |
Net Income | 352.0M | ↑ 29.89% |
Net Profit Margin | 7.33% | ↑ 1.1% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.1B | ↑ 4.39% |
Net Income | 89.4M | ↑ 4.56% |
Net Profit Margin | 7.86% | ↑ 0.01% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.2B | ↑ 2.03% |
Net Income | 87.7M | ↓ 1.9% |
Net Profit Margin | 7.56% | ↓ 0.3% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.2B | ↑ 2.3% |
Net Income | 91.4M | ↑ 4.22% |
Net Profit Margin | 7.7% | ↑ 0.14% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.2B | ↑ 1.67% |
Net Income | 85.3M | ↓ 6.67% |
Net Profit Margin | 7.07% | ↓ 0.63% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.2B | ↑ 3.31% |
Net Income | 87.6M | ↑ 2.7% |
Net Profit Margin | 7.03% | ↓ 0.04% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.3B | ↑ 5.55% |
Net Income | 112.5M | ↑ 28.42% |
Net Profit Margin | 8.55% | ↑ 1.52% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 5.2B | ↑ 6.82% |
Total Liabilities | 3.4B | ↑ 3.33% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.1B | ↑ 16.32% |
Total Liabilities | 4.1B | ↑ 23.59% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 6.4B | ↑ 6.01% |
Total Liabilities | 4.4B | ↑ 7.14% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 6.9B | ↑ 6.5% |
Total Liabilities | 4.5B | ↑ 0.48% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 5.6B | ↓ 17.89% |
Total Liabilities | 3.8B | ↓ 15.48% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 6.1B | ↑ 8.27% |
Total Liabilities | 3.8B | ↑ 0.81% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.6B | ↑ 2.93% |
Total Liabilities | 3.8B | ↑ 1.25% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.7B | ↑ 1.97% |
Total Liabilities | 3.8B | ↑ 0.25% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.9B | ↑ 1.98% |
Total Liabilities | 3.8B | ↑ 0.52% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.0B | ↑ 1.76% |
Total Liabilities | 3.8B | ↓ 0.76% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.1B | ↑ 2.32% |
Total Liabilities | 3.8B | ↑ 0.8% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 6.2B | ↑ 2.11% |
Total Liabilities | 3.8B | ↑ 0.6% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 762.4M | ↑ 16.01% |
Investing Cash Flow | -424.5M | ↑ 49.21% |
Financing Cash Flow | -321.2M | ↓ 10.75% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 635.3M | ↓ 16.67% |
Investing Cash Flow | -657.4M | ↑ 54.86% |
Financing Cash Flow | 48.2M | ↓ 115.01% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 704.7M | ↑ 10.92% |
Investing Cash Flow | -407.5M | ↓ 38.01% |
Financing Cash Flow | -145.9M | ↓ 402.7% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 715.8M | ↑ 1.58% |
Investing Cash Flow | -666.3M | ↑ 63.51% |
Financing Cash Flow | -240.1M | ↑ 64.56% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 705.8M | ↓ 1.4% |
Investing Cash Flow | -627.0M | ↓ 5.9% |
Financing Cash Flow | -145.7M | ↓ 39.32% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 172.2M | ↑ 145.65% |
Investing Cash Flow | -627.0M | ↑ 259.72% |
Financing Cash Flow | -16.5M | ↓ 66.33% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 227.9M | ↑ 32.35% |
Investing Cash Flow | -104.0M | ↓ 83.41% |
Financing Cash Flow | -58.0M | ↑ 251.52% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 206.7M | ↓ 9.3% |
Investing Cash Flow | -128.5M | ↑ 23.56% |
Financing Cash Flow | -43.5M | ↓ 25.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 215.2M | ↑ 4.11% |
Investing Cash Flow | -394.7M | ↑ 207.16% |
Financing Cash Flow | -65.8M | ↑ 51.26% |
Sell
Neutral
Buy
Encompass Health Corporation is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Encompass Health Corporation | 7.15% | 26.45% | 37.21% | 12.74% | 34.22% |
![]() Fresenius Medical Care Ag | 6.75% | 1.59% | -22.77% | -49.63% | -45.76% |
![]() Hca Holdings, Inc. | 3.62% | 24.47% | 25.02% | 43.55% | 143.2% |
![]() Tenet Healthcare Corp. | 10.35% | 80.65% | 95.1% | 108.93% | 580.33% |
![]() Universal Health Services Inc. | 8.08% | 30.09% | 44.94% | 32.59% | 34.96% |
![]() Davita Healthcare Partners Inc. | 0.24% | 32.97% | 40.81% | 19.01% | 139.9% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Encompass Health Corporation | 23.73 | 23.73 | NA | 4.11 | 0.23 | 0.08 | 0.01 | 17.3 |
![]() Fresenius Medical Care Ag | 22.58 | 22.58 | 0.39 | 1.5 | 0.05 | 0.03 | 0.03 | 47.4 |
![]() Hca Holdings, Inc. | 16.16 | 16.16 | 1.44 | 21.86 | 0.74 | 0.11 | 0.01 | -6.06 |
![]() Tenet Healthcare Corp. | 5.46 | 5.46 | 1.74 | 8.98 | 0.54 | 0.07 | NA | 16.09 |
![]() Universal Health Services Inc. | 15.8 | 15.8 | 1.87 | 13.79 | 0.13 | 0.06 | 0.0 | 93.48 |
![]() Davita Healthcare Partners Inc. | 16.31 | 16.31 | 1.16 | 9.32 | 0.43 | 0.06 | NA | 10.56 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Encompass Health Corporation | Buy | $9.1B | 34.22% | 23.73 | 7.6% |
![]() Fresenius Medical Care Ag | Hold | $11.9B | -45.76% | 22.58 | 2.48% |
![]() Hca Holdings, Inc. | Buy | $90.1B | 143.2% | 16.16 | 8.4% |
![]() Tenet Healthcare Corp. | Buy | $14.6B | 580.33% | 5.46 | 12.54% |
![]() Universal Health Services Inc. | Hold | $12.4B | 34.96% | 15.8 | 5.57% |
![]() Davita Healthcare Partners Inc. | Hold | $12.6B | 139.9% | 16.31 | 6.61% |
Insights on Encompass Health Corporation
Revenue is up for the last 7 quarters, 1.08B → 1.31B (in $), with an average increase of 3.1% per quarter
Netprofit is up for the last 3 quarters, 85.3M → 112.5M (in $), with an average increase of 12.4% per quarter
In the last 1 year, Tenet Healthcare Corp. has given 95.1% return, outperforming this stock by 57.9%
In the last 3 years, Tenet Healthcare Corp. has given 108.9% return, outperforming this stock by 96.2%
Vanguard Group Inc
BlackRock Inc
Wellington Management Company LLP
Amvescap Plc.
William Blair Investment Management, LLC
State Street Corporation
In the quarter ending December,2024. Encompass Health Corporation has declared dividend of $0.15
Read Moreas a national leader of post-acute care, encompass health offers facility-based and home-based patient care through our network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. we are committed to delivering high-quality, cost-effective care across the post-acute continuum. driven by a set of shared values, encompass health is the result of the union between healthsouth corporation and encompass home health & hospice.our approach to post-acute care sets us apart. we firmly believe that every success starts with our dedicated team of professionals, so we make sure they are empowered with the tools they need to help our patients be successful. innovative technologies, advanced therapies, customized treatment plans, coordinated care teams – these are all part of our promise to deliver the highest level of care.
Organization | Encompass Health Corporation |
Employees | 27209 |
CEO | Mr. Mark J. Tarr |
Industry | Health Services |
Outfront Media Inc.
$91.61
+1.07%
Blackrock Short Duration Bond Etf
$91.61
+1.07%
Moog Inc
$91.61
+1.07%
Edgio Inc.
$91.61
+1.07%
Invesco S&p 500 Momentum Etf
$91.61
+1.07%
Silicon Laboratories Inc
$91.61
+1.07%
Helmerich & Payne, Inc.
$91.61
+1.07%
Crane Nxt Co
$91.61
+1.07%
Liberty Global Plc - Class C Shares
$91.61
+1.07%